直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Prosecution First Blog

Non-Patent Literature, Fair Use, and the USPTO

April 19, 2016

Authored and Edited by Emily R. Florio, Stephanie M. Sanders

Copyrights and patents are two distinct types of intellectual property rights. Though copyrights and patents provide different types of IP protection, the two can intersect during patent prosecution. For example, an applicant may need to cite references to the USPTO in order to comply with the duty of disclosure. Such references may include U.S. or foreign patents and published patent applications, as well as publications, which are called non-patent literature (NPL) documents. NPL documents can be journal or magazine articles, technical reports, industry standards, dissertations or theses, product inserts, books, conference posters, and anything else that is not a patent or published patent application.

It is likely that a given NPL document will be copyrighted material. In order to be sure that submitting a copyrighted NPL document to the USPTO does not run afoul of copyright law, an applicant must ask whether the submission is considered fair use. The USPTO directly addresses this question—and provides some guidance to applicants—in its memorandum, USPTO Position on Fair Use of Copies of NPL Made in Patent Examination, dated January 19, 2012. The memorandum concludes that if an NPL document is obtained through “legitimate, licensed databases,” then the submission of that NPL document to the USPTO is considered fair use. In order to ensure that you are accessing documents from “legitimate, licensed databases,” you might want to speak with a law librarian.

Tags

United States Patent and Trademark Office (USPTO)

Related Practices

Patent Drafting and Prosecution

Copyright © 2016 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP